{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:35:09Z","timestamp":1793910909417,"version":"4.8.0"},"reference-count":105,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Candida auris<\/jats:italic>\n                    , an emerging fungus that exhibits a unique transmission ability, causes large healthcare-associated outbreaks on 6 continents since first reported in 2009. Most isolates have acquired fluconazole resistance, and resistance to other agents\/classes emerges during drug exposure. The emergence of\n                    <jats:italic toggle=\"yes\">C auris<\/jats:italic>\n                    infections raises serious concerns for public health. Systematic elaboration on clinical treatment and prevention of\n                    <jats:italic toggle=\"yes\">C auris<\/jats:italic>\n                    infections is rare. We aim to summarize the research progress on the risk factors, clinical signs, drug treatment and prevention of\n                    <jats:italic toggle=\"yes\">C auris<\/jats:italic>\n                    infections.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046610","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:00:10Z","timestamp":1766203210000},"page":"e46610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive strategies to defeat Candida auris \u2013 challenge and insight: A review"],"prefix":"10.1097","volume":"104","author":[{"given":"Jieyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Zhong","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Ye","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-1585","authenticated-orcid":false,"given":"Fei","family":"Cao","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xia","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hong","sequence":"additional","affiliation":[{"name":"Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40121-022-00625-9","article-title":"Candida auris candidemia in critically Ill, colonized patients: cumulative incidence and risk factors.","volume":"11","author":"Briano","year":"2022","journal-title":"Infect Dis Ther"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/jof8080787","article-title":"Emergence and genomic characterization of multidrug resistant Candida auris in Nigeria, West Africa.","volume":"8","author":"Oladele","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/jof5040103","article-title":"Thermogenic characterization and antifungal susceptibility of Candida auris by microcalorimetry.","volume":"5","author":"Di Luca","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"e1008921","DOI":"10.1371\/journal.ppat.1008921","article-title":"Candida auris: epidemiology, biology, antifungal resistance, and virulence.","volume":"16","author":"Du","year":"2020","journal-title":"PLoS Pathog"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JCM.00921-17","article-title":"Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface.","volume":"55","author":"Welsh","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fgene.2020.00554","article-title":"Understanding the emergence of multidrug-resistant Candida: using whole-genome sequencing to describe the population structure of Candida haemulonii species complex.","volume":"11","author":"Gade","year":"2020","journal-title":"Front Genet"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3201\/eid2509.190686","article-title":"Potential fifth clade of Candida auris, Iran, 2018.","volume":"25","author":"Chow","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"R11-20260522","first-page":"51","article-title":"First fluconazole-resistant Candida auris isolated from fungal otitis in Iran.","volume":"7","author":"Armaki","year":"2021","journal-title":"Curr Med Mycol"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","article-title":"Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3201\/eid2907.230540","article-title":"Candida auris\u2013associated hospitalizations, United States, 2017-2022.","volume":"29","author":"Benedict","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmi.2020.12.030","article-title":"Outbreak of Candida auris infection in a COVID-19 hospital in Mexico.","volume":"27","author":"Villanueva-Lozano","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"e03364","DOI":"10.1128\/mBio.03364-19","article-title":"Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses.","volume":"11","author":"Chow","year":"2020","journal-title":"mBio"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M22-3469","article-title":"Worsening spread of Candida auris in the United States, 2019 to 2021.","volume":"176","author":"Lyman","year":"2023","journal-title":"Ann Intern Med"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5694\/mja2.50612","article-title":"Candida auris in an Australian health care facility: importance of screening high risk patients.","volume":"212","author":"Worth","year":"2020","journal-title":"Med J Aust"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/jof9040430","article-title":"The mortality attributable to candidemia in C. auris is higher than that in other Candida species: myth or reality?","volume":"9","author":"Alvarez-Moreno","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"658329","DOI":"10.3389\/fmicb.2021.658329","article-title":"Retrospective analysis of the clinical characteristics of Candida auris infection worldwide from 2009 to 2020.","volume":"12","author":"Hu","year":"2021","journal-title":"Front Microbiol"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cmi.2020.02.001","article-title":"A clinical predictive model of Candidaemia by CandidaCandidaemia by Candida auris in previously colonized critically ill patients.","volume":"26","author":"Garcia-Bustos","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41426-018-0131-0","article-title":"First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China.","volume":"7","author":"Tian","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/antibiotics9090557","article-title":"Candida auris bloodstream infections in Russia.","volume":"9","author":"Barantsevich","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41579-019-0254-x","article-title":"Candida auris\u2019 potential link to climate change.","volume":"17","author":"Hofer","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pathogens10020157","article-title":"First Candida auris outbreak during a COVID-19 Pandemic in a tertiary-care center in Lebanon.","volume":"10","author":"Allaw","year":"2021","journal-title":"Pathogens"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41591-021-01383-w","article-title":"Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility.","volume":"27","author":"Proctor","year":"2021","journal-title":"Nat Med"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"e01604","DOI":"10.1128\/JCM.01604-18","article-title":"A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD Max System.","volume":"57","author":"Lima","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semdp.2019.04.010","article-title":"Emerging and reemerging fungal infections.","volume":"36","author":"Lockhart","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"1900730","DOI":"10.2807\/1560-7917.ES.2021.26.8.1900730","article-title":"Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018.","volume":"26","author":"Sharp","year":"2021","journal-title":"Euro Surveill"},{"key":"R31-20260522","first-page":"326","article-title":"Incidence of candidemia and prevalence of azole-resistant candidemia at a tertiary South African hospital - A retrospective laboratory analysis 2016-2020.","volume":"37","author":"Chibabhai","year":"2022","journal-title":"S Afr J Infect Dis"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2352-4642(21)00272-8","article-title":"Neonatal invasive candidiasis: updates on clinical management and prevention.","volume":"6","author":"Kilpatrick","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R33-20260522","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jac\/dkz280","article-title":"In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.","volume":"74","author":"Rudramurthy","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R34-20260522","doi-asserted-by":"crossref","first-page":"e02233","DOI":"10.1128\/AAC.02233-18","article-title":"The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris.","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-20260522","doi-asserted-by":"crossref","first-page":"e02438","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin In vitro activity against contemporary nordic clinical Candida isolates and Candida auris determined by the EUCAST reference method.","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-20260522","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/microorganisms9040863","article-title":"Comparison of in vitro killing activity of rezafungin, anidulafungin, caspofungin, and micafungin against four Candida auris Clades in RPMI-1640 in the absence and presence of human serum.","volume":"9","author":"Kov\u00e1cs","year":"2021","journal-title":"Microorganisms"},{"key":"R37-20260522","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of Candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"key":"R38-20260522","doi-asserted-by":"crossref","first-page":"e02136","DOI":"10.1128\/AAC.02136-19","article-title":"In vitro activity of ibrexafungerp (SCY-078) against Candida auris Isolates as determined by EUCAST methodology and comparison with activity against C. albicans and C. glabrata and with the activities of six comparator agents.","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-20260522","doi-asserted-by":"crossref","first-page":"e02694","DOI":"10.1128\/AAC.02694-20","article-title":"Ibrexafungerp demonstrates in vitro activity against fluconazole-resistant Candida auris and in vivo efficacy with delayed initiation of therapy in an experimental model of invasive candidiasis.","volume":"65","author":"Wiederhold","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-20260522","doi-asserted-by":"crossref","first-page":"906563","DOI":"10.3389\/fcimb.2022.906563","article-title":"In vitro antifungal activity of ibrexafungerp (SCY-078) against contemporary blood isolates from medically relevant species of Candida: a European study.","volume":"12","author":"Quind\u00f3s","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R41-20260522","doi-asserted-by":"crossref","first-page":"e0171721","DOI":"10.1128\/spectrum.01717-21","article-title":"In vitro antifungal activity of manogepix and other antifungal agents against South African Candida auris isolates from bloodstream infections.","volume":"10","author":"Maphanga","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R42-20260522","doi-asserted-by":"crossref","first-page":"e01120","DOI":"10.1128\/AAC.01120-19","article-title":"Efficacy of delayed therapy with fosmanogepix (APX001) in a murine model of Candida auris invasive candidiasis.","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-20260522","doi-asserted-by":"crossref","first-page":"e0141922","DOI":"10.1128\/aac.01419-22","article-title":"Clinical efficacy and safety of a novel antifungal, fosmanogepix, in patients with candidemia caused by Candida auris: results from a Phase 2 Trial.","volume":"67","author":"Vazquez","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"R44-20260522","doi-asserted-by":"crossref","first-page":"e02198","DOI":"10.1128\/AAC.02198-19","article-title":"The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against Candida auris.","volume":"64","author":"Wiederhold","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R45-20260522","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.3390\/ijms232416042","article-title":"The arylamidine T-2307 as a novel treatment for the prevention and eradication of Candida tropicalis biofilms.","volume":"23","author":"Maione","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R46-20260522","doi-asserted-by":"crossref","first-page":"126621","DOI":"10.1016\/j.micres.2020.126621","article-title":"What do we know about the biology of the emerging fungal pathogen of humans Candida auris?","volume":"242","author":"Bravo Ruiz","year":"2021","journal-title":"Microbiol Res"},{"key":"R47-20260522","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/myc.13419","article-title":"Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.","volume":"65","author":"Asadzadeh","year":"2022","journal-title":"Mycoses"},{"key":"R48-20260522","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cell.2021.01.016","article-title":"Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies.","volume":"184","author":"Doron","year":"2021","journal-title":"Cell"},{"key":"R49-20260522","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.3390\/ijms22116162","article-title":"Candida cell-surface-specific monoclonal antibodies protect mice against Candida auris invasive infection.","volume":"22","author":"Rosario-Colon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R50-20260522","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/jof9010103","article-title":"Protective efficacy of Anti-Hyr1p monoclonal antibody against systemic candidiasis due to multi-drug-resistant Candida auris.","volume":"9","author":"Singh","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"R51-20260522","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.abd6919","article-title":"A marine microbiome antifungal targets urgent-threat drug-resistant fungi.","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"R52-20260522","doi-asserted-by":"crossref","first-page":"e145123","DOI":"10.1172\/JCI145123","article-title":"Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking.","volume":"131","author":"Zhao","year":"2021","journal-title":"J Clin Invest"},{"key":"R53-20260522","doi-asserted-by":"crossref","first-page":"2208687","DOI":"10.1080\/22221751.2023.2208687","article-title":"Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections.","volume":"12","author":"Tu","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"R54-20260522","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.3390\/ijms24129788","article-title":"Cm-p5 peptide dimers inhibit biofilms of Candida albicans clinical isolates, C. parapsilosis and fluconazole-resistant mutants of C. auris.","volume":"24","author":"Amann","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R55-20260522","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/antibiotics9070363","article-title":"Derivates of the antifungal peptide Cm-p5 Inhibit development of Candida auris Biofilms in vitro.","volume":"9","author":"Kubiczek","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R56-20260522","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/jof8020204","article-title":"Antifungal activity of human cathelicidin LL-37, a membrane disrupting peptide, by triggering oxidative stress and cell cycle arrest in Candida auris.","volume":"8","author":"Rather","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R57-20260522","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3389\/fmicb.2020.01673","article-title":"silver nanoantibiotics display strong antifungal activity against the emergent multidrug-resistant yeast Candida auris under both planktonic and biofilm growing conditions.","volume":"11","author":"Vazquez-Munoz","year":"2020","journal-title":"Front Microbiol"},{"key":"R58-20260522","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/jof8070744","article-title":"Silver nanoparticles: a promising antifungal agent against the growth and biofilm formation of the emergent Candida auris.","volume":"8","author":"AlJindan","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R59-20260522","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/antibiotics9080461","article-title":"Bismuth nanoantibiotics display anticandidal activity and disrupt the biofilm and cell morphology of the emergent pathogenic yeast candidacandidal activity and disrupt the biofilm and cell morphology of the emergent pathogenic yeast Candida auris.","volume":"9","author":"Vazquez-Munoz","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R60-20260522","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/antiox10020182","article-title":"Phytogenic fabrication of ag-fe bimetallic nanoparticles for cell cycle arrest and apoptosis signaling pathways in Candida auris by generating oxidative stress.","volume":"10","author":"Kamli","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R61-20260522","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/jof7010062","article-title":"Facile bio-fabrication of Ag-Cu-Co trimetallic nanoparticles and its fungicidal activity against Candida auris.","volume":"7","author":"Kamli","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"R62-20260522","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jam.14490","article-title":"Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro.","volume":"128","author":"Gowri","year":"2020","journal-title":"J Appl Microbiol"},{"key":"R63-20260522","doi-asserted-by":"crossref","first-page":"e02331","DOI":"10.1128\/AAC.02331-19","article-title":"Derivatives of the antimalarial drug mefloquine are broad-spectrum antifungal molecules with activity against drug-resistant clinical isolates.","volume":"64","author":"Montoya","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R64-20260522","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jiac.2020.12.012","article-title":"Identification of disulfiram as a potential antifungal drug by screening small molecular libraries.","volume":"27","author":"Hao","year":"2021","journal-title":"J Infect Chemother"},{"key":"R65-20260522","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jare.2020.11.002","article-title":"Piperidine based 1,2,3-triazolylacetamide derivatives induce cell cycle arrest and apoptotic cell death in Candida auris.","volume":"29","author":"Srivastava","year":"2021","journal-title":"J Adv Res"},{"key":"R66-20260522","doi-asserted-by":"crossref","first-page":"128922","DOI":"10.1016\/j.bmcl.2022.128922","article-title":"Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative.","volume":"73","author":"Wani","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"R67-20260522","doi-asserted-by":"crossref","first-page":"e0285473","DOI":"10.1371\/journal.pone.0285473","article-title":"Cellular apoptosis and cell cycle arrest as potential therapeutic targets for eugenol derivatives in Candida auris.","volume":"18","author":"Alam","year":"2023","journal-title":"PLoS One"},{"key":"R68-20260522","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/mmy\/myab032","article-title":"In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.","volume":"59","author":"Nagy","year":"2021","journal-title":"Med Mycol"},{"key":"R69-20260522","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/antibiotics11111601","article-title":"Synergistic interaction of caspofungin combined with posaconazole against FKS wild-type and mutant Candida auris planktonic cells and biofilms.","volume":"11","author":"Balla","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R70-20260522","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s42770-022-00817-y","article-title":"Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris.","volume":"53","author":"Alan\u00eds-R\u00edos","year":"2022","journal-title":"Braz J Microbiol"},{"key":"R71-20260522","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/pharmaceutics13091333","article-title":"In vitro interaction and killing-kinetics of amphotericin B combined with anidulafungin or caspofungin against Candida auris.","volume":"13","author":"Caballero","year":"2021","journal-title":"Pharmaceutics"},{"key":"R72-20260522","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/jof5040092","article-title":"Repositionable compounds with antifungal activity against multidrug resistant Candida auris identified in the medicines for malaria venture\u2019s pathogen box.","volume":"5","author":"Wall","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"R73-20260522","doi-asserted-by":"crossref","first-page":"106049","DOI":"10.1016\/j.ijantimicag.2020.106049","article-title":"Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.","volume":"56","author":"Barreto","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R74-20260522","doi-asserted-by":"crossref","first-page":"e02063-19","DOI":"10.1128\/AAC.02063-19","article-title":"In vitro antifungal susceptibility of the emerging multidrug-resistant pathogen Candida auris to miltefosine alone and in combination with amphotericin B.","volume":"64","author":"Wu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R75-20260522","doi-asserted-by":"crossref","first-page":"105901","DOI":"10.1016\/j.ijantimicag.2020.105901","article-title":"Colistin interacts synergistically with echinocandins against Candida auris.","volume":"55","author":"Bidaud","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R76-20260522","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/jof8020115","article-title":"In vitro activity of amphotericin B in combination with colistin against fungi responsible for invasive infections.","volume":"8","author":"Schwarz","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R77-20260522","doi-asserted-by":"crossref","first-page":"21448","DOI":"10.1038\/s41598-020-78588-5","article-title":"In vitro synergy of isavuconazole in combination with colistin against Candida auris.","volume":"10","author":"Schwarz","year":"2020","journal-title":"Sci Rep"},{"key":"R78-20260522","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41467-023-37573-y","article-title":"A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi.","volume":"14","author":"Dos Reis","year":"2023","journal-title":"Nat Commun"},{"key":"R79-20260522","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/pathogens11080821","article-title":"Antifungal activity of select essential oils against Candida auris and their interactions with antifungal drugs.","volume":"11","author":"Parker","year":"2022","journal-title":"Pathogens"},{"key":"R80-20260522","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/jof9060648","article-title":"In vitro and in vivo activity of citral in combination with amphotericin B, anidulafungin and fluconazole against Candida auris Isolates.","volume":"9","author":"de-la-Fuente","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"R81-20260522","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/jof9060663","article-title":"Clorgyline analogs synergize with azoles against drug efflux in Candida auris.","volume":"9","author":"Toepfer","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"R82-20260522","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhin.2023.04.007","article-title":"Survival of Candida auris on environmental surface materials and low-level resistance to disinfectant.","volume":"137","author":"Dire","year":"2023","journal-title":"J Hosp Infect"},{"key":"R83-20260522","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhin.2019.06.006","article-title":"Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence.","volume":"103","author":"Short","year":"2019","journal-title":"J Hosp Infect"},{"key":"R84-20260522","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhin.2017.09.009","article-title":"Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions.","volume":"97","author":"Biswal","year":"2017","journal-title":"J Hosp Infect"},{"key":"R88-20260522","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital.","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"R89-20260522","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2019.08.013","article-title":"Control of Candida auris in healthcare institutions: outcome of an international society for antimicrobial chemotherapy expert meeting.","volume":"54","author":"Kenters","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"R91-20260522","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12879-021-06131-6","article-title":"Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study.","volume":"21","author":"Sathyapalan","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R92-20260522","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/ice.2020.414","article-title":"Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia.","volume":"42","author":"Alshamrani","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 7","key":"R93-20260522","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imj.15586","article-title":"Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021.","volume":"51","author":"Khanina","year":"2021","journal-title":"Intern Med J"},{"key":"R96-20260522","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/jof7100804","article-title":"Augmenting the activity of chlorhexidine for decolonization of Candida auris from porcine skin.","volume":"7","author":"Johnson","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"R97-20260522","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12879-019-4137-6","article-title":"The efficacy of pulsed-xenon ultraviolet light technology on Candida auris.","volume":"19","author":"Maslo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R98-20260522","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/myc.12903","article-title":"Killing of Candida auris by UV-C: Importance of exposure time and distance.","volume":"62","author":"de Groot","year":"2019","journal-title":"Mycoses"},{"key":"R99-20260522","doi-asserted-by":"crossref","first-page":"101178","DOI":"10.1016\/j.mycmed.2021.101178","article-title":"The effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris.","volume":"31","author":"Zatorska","year":"2021","journal-title":"J Mycol Med"},{"key":"R100-20260522","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/antibiotics9090558","article-title":"Characteristics and management of candidaemia episodes in an established candidacandidaemia episodes in an established candida auris outbreak.","volume":"9","author":"Mulet Bayona","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R101-20260522","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10096-023-04723-5","article-title":"Can daily bathing with 4% chlorhexidine + daily chlorhexidine wipe for 1 week be effective in decolonizing Candida auris colonization?","volume":"43","author":"Elbahr","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R102-20260522","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jiac.2021.09.018","article-title":"Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris.","volume":"28","author":"Hao","year":"2022","journal-title":"J Infect Chemother"},{"key":"R103-20260522","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ajic.2022.11.010","article-title":"Efficacy of chlorhexidine in advanced performance technology formulation in decolonizing the skin using Candida auris skin colonization mouse model.","volume":"51","author":"Elshaer","year":"2023","journal-title":"Am J Infect Control"},{"key":"R104-20260522","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1017\/ice.2020.410","article-title":"Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light (UV-C).","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R105-20260522","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/ice.2021.206","article-title":"Efficacy of relatively low-cost ultraviolet-C light devices against Candida auris.","volume":"43","author":"Pearlmutter","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R106-20260522","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhin.2021.12.004","article-title":"Effectiveness of ultraviolet-C vs aerosolized hydrogen peroxide in ICU terminal disinfection.","volume":"121","author":"Kelly","year":"2022","journal-title":"J Hosp Infect"},{"key":"R107-20260522","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1017\/ice.2021.214","article-title":"Inactivation of Candida auris and Candida albicans by ultraviolet-C.","volume":"43","author":"Rutala","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R108-20260522","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajic.2023.08.018","article-title":"Ultraviolet-C mediated inactivation of Candida auris, a rapid emerging health threat.","volume":"52","author":"Koutras","year":"2023","journal-title":"Am J Infect Control"},{"key":"R109-20260522","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1038\/s41598-023-32876-y","article-title":"Contact time and disinfectant formulation significantly impact the efficacies of disinfectant towelettes against Candida auris on hard, non-porous surfaces.","volume":"13","author":"Voorn","year":"2023","journal-title":"Sci Rep"},{"key":"R110-20260522","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajic.2022.06.021","article-title":"The evaluation of electrolyzed water, sodium dichloroisocyanurate, and peracetic acid with hydrogen peroxide for the disinfection of patient room surfaces.","volume":"51","author":"Solomon","year":"2023","journal-title":"Am J Infect Control"},{"key":"R111-20260522","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s44197-023-00154-9","article-title":"Characteristics and mitigation measures of Candida auris infection: descriptive analysis from a quaternary care hospital in Saudi Arabia, 2021-2022.","volume":"13","author":"Amer","year":"2023","journal-title":"J Epidemiol Glob Health"},{"key":"R112-20260522","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/myc.13443","article-title":"Successful control of Candida auris transmission in a German COVID-19 intensive care unit.","volume":"65","author":"Hinrichs","year":"2022","journal-title":"Mycoses"},{"key":"R113-20260522","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.7326\/M21-2013","article-title":"Rapid assessment and containment of Candida auris transmission in postacute care settings-Orange County, California, 2019.","volume":"174","author":"Karmarkar","year":"2021","journal-title":"Ann Intern Med"},{"key":"R114-20260522","doi-asserted-by":"crossref","first-page":"260","DOI":"10.20411\/pai.v4i2.291","article-title":"Environmental contamination with Candida species in multiple hospitals including a tertiary care hospital with a Candida auris outbreak.","volume":"4","author":"Kumar","year":"2019","journal-title":"Pathog Immun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:00:38Z","timestamp":1779433238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":105,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046610","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2024-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}